🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.47
-0.16 (-1.85%)
At close: Nov 18, 2026, 4:00 PM EST
8.31
-0.16 (-1.94%)
Pre-market: Nov 19, 2026, 7:00 AM EST

Grifols Revenue

Grifols had revenue of 7.42B EUR in the twelve months ending June 30, 2026, up 2.90% year-over-year. In the year 2025, Grifols had annual revenue of 7.52B with 4.33% growth.

Revenue (ttm)
7.42B EUR
Revenue Growth
+2.90%
P/S Ratio
0.87
Revenue / Employee
296,842 EUR
Employees
25,000
Market Cap
7.50B USD

Revenue Chart

* This company reports financials in EUR.

Revenue by Segment

By Segment

Chart
  • Biopharma 6.49B 86.2%
  • Diagnostic 640.00M 8.5%
  • Others 243.00M 3.2%
  • Bio Supplies 154.00M 2.0%

By Geography

Chart
  • USA and Canada 4.25B 56.5%
  • Rest of the World 1.66B 22.0%
  • Rest of European Union 1.20B 15.9%
  • Spain 418.00M 5.6%
Fiscal year ended Dec 31, 2025 See the full Grifols breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.52B312.00M4.33%
Dec 31, 20247.21B620.02M9.41%
Dec 31, 20236.59B528.01M8.71%
Dec 31, 20226.06B1.13B22.92%
Dec 31, 20214.93B-406.92M-7.62%
Dec 31, 20205.34B241.35M4.73%
Dec 31, 20195.10B611.97M13.64%
Dec 31, 20184.49B168.65M3.91%
Dec 31, 20174.32B268.24M6.62%
Dec 31, 20164.05B115.27M2.93%
Dec 31, 20153.93B579.18M17.26%
Dec 31, 20143.36B613.65M22.38%
Dec 31, 20132.74B120.79M4.61%
Dec 31, 20122.62B825.33M45.96%
Dec 31, 20111.80B804.88M81.24%
Dec 31, 2010990.73M77.54M8.49%
Dec 31, 2009913.19M98.88M12.14%
Dec 31, 2008814.31M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Pfizer63.62B
AstraZeneca62.38B
Sanofi57.89B
Novo Nordisk50.70B
Bristol-Myers Squibb Company50.03B
GSK plc44.53B
Amgen38.90B
Gilead Sciences30.99B
Revenue Rankings